ahlam1399
10-03-2016, 11:00 PM
Spectral Medical?s sepsis treatment fails late-stage study
(Reuters) - Spectral Medical Inc said its experimental treatment for sepsis - a common, oft-deadly complication of infection - failed a late-stage study, stymieing the company's plans to bring to market the first FDA-approved device for the condition.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=VkJviNpo2Hc:ez0smzhqWe8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=VkJviNpo2Hc:ez0smzhqWe8:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=VkJviNpo2Hc:ez0smzhqWe8:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=VkJviNpo2Hc:ez0smzhqWe8:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=VkJviNpo2Hc:ez0smzhqWe8:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/VkJviNpo2Hc
(Reuters) - Spectral Medical Inc said its experimental treatment for sepsis - a common, oft-deadly complication of infection - failed a late-stage study, stymieing the company's plans to bring to market the first FDA-approved device for the condition.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=VkJviNpo2Hc:ez0smzhqWe8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=VkJviNpo2Hc:ez0smzhqWe8:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=VkJviNpo2Hc:ez0smzhqWe8:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=VkJviNpo2Hc:ez0smzhqWe8:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=VkJviNpo2Hc:ez0smzhqWe8:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/VkJviNpo2Hc